available data

[키워드] 2019 novel coronavirus 2019-nCoV Admission adverse outcome adverse outcomes Analysis association assumed autonomous available data calculate Care changes in Characteristics chest radiology China clinical Clinical characteristics Clinical outcome clinical symptom clinically cohort study conducted coronavirus Course COVID-19 COVID-19 pandemic current database death deaths detrimental diagnosed died discharged disease Disease progression English epidemiological evaluate Evidence Factor feature FIVE former Health hospital hospitalisation hospitalised patient Hospitalization humans ICU ICU care immune system inclusion criteria Increases indicated individual infected with COVID-19 infected with SARS-CoV-2 infections Infectious disease Influenza information Inpatient intensive care Italy Laboratory laboratory-confirmed Logistic regression Logistic regression analysis lung majority mechanical ventilation MERS-CoV Mortality mortality risk factor multicenter cohort study multicentre multivariate multivariate logistic regression negative non-ICU non-severe patient non-survivor outbreak outcome pandemic Patient patients patients died patients with COVID-19 percentage plethora Population positive previous study Prognosis Prognostic factor progression proportion Prospective provided pulmonary ranged Region regions reported Research Respiratory disease retrieved retrospective retrospective cohort study risk factor Sample size searched setting Severe case Severe patient severe symptom severe symptoms severity shown significantly higher small sample size smoker Smokers smoking smoking status statistical analysis statistically significant statistically significant difference Study design study population Support survived survivor Symptom Symptoms systematic review table tested the disease the patient those that survived title Tobacco two group were excluded were used with COVID-19 Wuhan Wuhan, China
[DOI] 10.18332/tid/119324 PMC 바로가기 [Article Type] Editorial